KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Operating Income (2016 - 2025)

Historic Operating Income for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $2.7 billion.

  • Amgen's Operating Income rose 1769.8% to $2.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 billion, marking a year-over-year increase of 2510.33%. This contributed to the annual value of $9.1 billion for FY2025, which is 2510.33% up from last year.
  • Amgen's Operating Income amounted to $2.7 billion in Q4 2025, which was up 1769.8% from $2.5 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Operating Income ranged from a high of $2.7 billion in Q4 2025 and a low of $828.0 million during Q2 2021
  • In the last 5 years, Amgen's Operating Income had a median value of $2.2 billion in 2022 and averaged $2.1 billion.
  • Its Operating Income has fluctuated over the past 5 years, first plummeted by 6435.64% in 2021, then soared by 16280.19% in 2022.
  • Amgen's Operating Income (Quarter) stood at $2.3 billion in 2021, then dropped by 3.21% to $2.2 billion in 2022, then tumbled by 43.0% to $1.3 billion in 2023, then skyrocketed by 81.83% to $2.3 billion in 2024, then rose by 17.7% to $2.7 billion in 2025.
  • Its Operating Income was $2.7 billion in Q4 2025, compared to $2.5 billion in Q3 2025 and $2.7 billion in Q2 2025.